CHIRON - Guérisseur Blessé
Food supplement declared in France, declaration No 2023-9-592
CHIRON - Guérisseur Blessé (Elixir Alchimique) is a food supplement declared in France. Status: retrait du marché annoncé pour le 30 September 2028. None of the rules we check flags an issue with its declared composition.
- Brand
- Elixir Alchimique
- Food business operator placing the product on the market
- VITURET Florent
- Status
- Retrait du marché annoncé pour le 30 September 2028
- Form
- Compte-gouttes
- Daily dose
- 90 gouttes soit 834mg d'extrait
- Directions for use
- 30 gouttes diluées dans un verre d'eau, 3 fois par jour pendant 3 semaines.
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Sous anticoagulants, Sous antidépresseurs, Sous antidiabétiques, Sous traitement antihypertenseur, Sous traitement médicamenteux, Sous traitement pour la thyroïde, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Humeur, Système nerveux
Declaration 272281, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 30 September 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Achillea millefolium L. | Sommités fleuries | Alcoolature | 335 mg |
| Hypericum perforatum L. | Sommités fleuries | Alcoolature | 206 mg |
| Verbena officinalis L. | Parties aériennes | Alcoolature | 129 mg |
| Corylus avellana L. | Bourgeon | Autre macérât | 60 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
| Eau de mer | not declared |
Other ingredients
Eau osmosée dynamisée, Alcool
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ce produit additionne les contre-indications de chacune des plantes qui le compose, il est donc contre-indiqué à la femme enceinte, allaitante, à l'enfant de moins de 18 ans et à toutes personnes sous traitement médicamenteux. Attention aux Allergies aux Astéracées.Détail :Le millepertuis est contre-indiqué pour la femme enceinte et allaitante, à l'adolescent de moins de 18 ans et à toutes personnes étant sous traitement médicamenteux. Les interactions du millepertuis sont complexes mais nous savons qu'il interagie avec le substrat 3A4 du CYP450, nous le contre-indiquons donc par mesure de précaution à toute associations médicamenteuses.L'Achillée Millefeuille est contre-indiqué en cas de prise d'anticoagulant, mais le produit est contre-indiqué aux personnes sous traitement médicamenteux. Aussi, nécessite de faire attention aux allergies aux Astéracées.La Verveine Officinale et le Noisetier n'ajoutent pas de contre-indications supplémentaires.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Hypericum perforatum L.
Read the warning, when it applies and the studies cited
ST. JOHN'S WORT -HYPERICUM PERFORATUM- Oral
Cautions and warnings
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a psychological disorder such as anxiety or depression.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking seizure medications, antihistamines, bronchodilators, muscle relaxants and/or opiates (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005; Kawaguchi et al. 2004; Morimoto et al. 2004; Eich-Höchli et al. 2003; Dresser et al. 2003; Hoffman 2003; Markowitz et al. 2003; Xie et al. 2003; Dannawi 2002; Gurley et al. 2002; Spinella and Eaton 2002; Wang et al. 2002; Parker et al. 2001; Wang et al. 2001; Burstein et al. 2000; Nebel et al. 1999).
18 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid prolonged exposure to sunlight, ultraviolet light (UV) or UV therapy (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003; Hoffmann 2003; McGuffin et al. 1997).
6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Bilia et al. 2002; Ernst et al. 1998).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are taking antidepressants, anxiolytics, anti-cancer, cardiovascular, contraceptive medications, blood thinners, anti-HIV agents and/or medications to suppress the immune system (Brinker 2010; Barnes et al. 2007; Bradley 2006; Mills and Bone 2005; Murphy et al. 2005; Frye et al. 2004; Hebert et al. 2004; Jiang et al. 2004; Mueller et al. 2004; Smith et al. 2004; Sparreboom et al. 2004; Tannergren et al. 2004; Wichtl 2004; Alscher and Klotz 2003; Bauer et al. 2003; Dresser et al. 2003; ESCOP 2003; Hall et al. 2003; Hoffmann 2003; Pfrunder et al. 2003; Schwarz et al. 2003; Bolley 2002; Gorski et al. 2002; Mathijssen et al. 2002; Ahmed et al. 2001; De Maat et al. 2001; Moschella and Jaber 2001; Roby et al. 2001; Sugimoto et al. 2001; Turton-Weeks 2001; Wang et al. 2001; Barone et al. 2000; Durr et al. 2000; Karliova et al. 2000; Mai et al. 2000; Piscitelli et al. 2000; Ruschitzka et al. 2000; Ernst 1999; Johne et al. 1999; Maurer et al. 1999; Rey and Walter 1998).
41 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience mild gastrointestinal disturbances, restlessness, and/or headaches (Barnes et al. 2007; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience muscle rigidity or contractions, tremors, agitation/confusion, increased heart rate, or hypersensitivity/allergy (Boyer 2023; Mayo Clinic Staff 2022; Erner et al. 2003; Papakostas et al. 2007; Barnes et al. 2007; ESCOP 2003).
6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 26 July 2024
ST. JOHN'S WORT - HYPERICUM PERFORATUM - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Elixir Alchimique
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.